vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.

Revolve Group, Inc. is the larger business by last-quarter revenue ($324.4M vs $284.0M, roughly 1.1× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 5.7%, a 90.6% gap on every dollar of revenue. On growth, Revolve Group, Inc. posted the faster year-over-year revenue change (10.4% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 9.5%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.

ACAD vs RVLV — Head-to-Head

Bigger by revenue
RVLV
RVLV
1.1× larger
RVLV
$324.4M
$284.0M
ACAD
Growing faster (revenue YoY)
RVLV
RVLV
+1.0% gap
RVLV
10.4%
9.4%
ACAD
Higher net margin
ACAD
ACAD
90.6% more per $
ACAD
96.3%
5.7%
RVLV
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
9.5%
RVLV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
RVLV
RVLV
Revenue
$284.0M
$324.4M
Net Profit
$273.6M
$18.6M
Gross Margin
90.8%
53.3%
Operating Margin
6.1%
6.3%
Net Margin
96.3%
5.7%
Revenue YoY
9.4%
10.4%
Net Profit YoY
90.3%
50.4%
EPS (diluted)
$1.61
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
RVLV
RVLV
Q4 25
$284.0M
$324.4M
Q3 25
$278.6M
$295.6M
Q2 25
$264.6M
$309.0M
Q1 25
$244.3M
$296.7M
Q4 24
$259.6M
$293.7M
Q3 24
$250.4M
$283.1M
Q2 24
$242.0M
$282.5M
Q1 24
$205.8M
$270.6M
Net Profit
ACAD
ACAD
RVLV
RVLV
Q4 25
$273.6M
$18.6M
Q3 25
$71.8M
$21.2M
Q2 25
$26.7M
$10.2M
Q1 25
$19.0M
$11.8M
Q4 24
$143.7M
$12.3M
Q3 24
$32.8M
$11.0M
Q2 24
$33.4M
$15.4M
Q1 24
$16.6M
$10.9M
Gross Margin
ACAD
ACAD
RVLV
RVLV
Q4 25
90.8%
53.3%
Q3 25
92.2%
54.6%
Q2 25
92.2%
54.1%
Q1 25
91.7%
52.0%
Q4 24
91.6%
52.5%
Q3 24
92.5%
51.2%
Q2 24
92.5%
54.0%
Q1 24
88.8%
52.3%
Operating Margin
ACAD
ACAD
RVLV
RVLV
Q4 25
6.1%
6.3%
Q3 25
12.8%
7.1%
Q2 25
12.2%
5.8%
Q1 25
7.9%
5.0%
Q4 24
59.1%
3.9%
Q3 24
12.6%
5.0%
Q2 24
12.6%
5.8%
Q1 24
7.4%
3.4%
Net Margin
ACAD
ACAD
RVLV
RVLV
Q4 25
96.3%
5.7%
Q3 25
25.8%
7.2%
Q2 25
10.1%
3.3%
Q1 25
7.8%
4.0%
Q4 24
55.4%
4.2%
Q3 24
13.1%
3.9%
Q2 24
13.8%
5.4%
Q1 24
8.0%
4.0%
EPS (diluted)
ACAD
ACAD
RVLV
RVLV
Q4 25
$1.61
$0.27
Q3 25
$0.42
$0.29
Q2 25
$0.16
$0.14
Q1 25
$0.11
$0.16
Q4 24
$0.86
$0.18
Q3 24
$0.20
$0.15
Q2 24
$0.20
$0.21
Q1 24
$0.10
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
RVLV
RVLV
Cash + ST InvestmentsLiquidity on hand
$177.7M
$292.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$512.5M
Total Assets
$1.6B
$765.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
RVLV
RVLV
Q4 25
$177.7M
$292.3M
Q3 25
$258.0M
$315.4M
Q2 25
$253.6M
$310.7M
Q1 25
$217.7M
$300.8M
Q4 24
$319.6M
$256.6M
Q3 24
$155.1M
$252.8M
Q2 24
$177.1M
$244.7M
Q1 24
$204.7M
$273.4M
Stockholders' Equity
ACAD
ACAD
RVLV
RVLV
Q4 25
$1.2B
$512.5M
Q3 25
$917.3M
$490.2M
Q2 25
$822.4M
$468.6M
Q1 25
$765.2M
$453.4M
Q4 24
$732.8M
$437.8M
Q3 24
$577.2M
$420.8M
Q2 24
$516.7M
$405.8M
Q1 24
$464.0M
$389.9M
Total Assets
ACAD
ACAD
RVLV
RVLV
Q4 25
$1.6B
$765.0M
Q3 25
$1.3B
$751.3M
Q2 25
$1.2B
$722.9M
Q1 25
$1.1B
$713.9M
Q4 24
$1.2B
$665.5M
Q3 24
$976.9M
$670.9M
Q2 24
$914.1M
$657.8M
Q1 24
$855.1M
$650.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
RVLV
RVLV
Operating Cash FlowLast quarter
$-48.7M
$-10.2M
Free Cash FlowOCF − Capex
$-13.3M
FCF MarginFCF / Revenue
-4.1%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
-0.18×
-0.55×
TTM Free Cash FlowTrailing 4 quarters
$48.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
RVLV
RVLV
Q4 25
$-48.7M
$-10.2M
Q3 25
$74.3M
$11.8M
Q2 25
$64.0M
$12.6M
Q1 25
$20.3M
$45.1M
Q4 24
$40.4M
$3.9M
Q3 24
$63.2M
$9.1M
Q2 24
$25.0M
$-24.7M
Q1 24
$29.1M
$38.4M
Free Cash Flow
ACAD
ACAD
RVLV
RVLV
Q4 25
$-13.3M
Q3 25
$73.9M
$7.5M
Q2 25
$10.4M
Q1 25
$43.4M
Q4 24
$2.1M
Q3 24
$63.2M
$8.0M
Q2 24
$-25.7M
Q1 24
$36.7M
FCF Margin
ACAD
ACAD
RVLV
RVLV
Q4 25
-4.1%
Q3 25
26.5%
2.5%
Q2 25
3.4%
Q1 25
14.6%
Q4 24
0.7%
Q3 24
25.2%
2.8%
Q2 24
-9.1%
Q1 24
13.5%
Capex Intensity
ACAD
ACAD
RVLV
RVLV
Q4 25
1.0%
Q3 25
0.1%
1.5%
Q2 25
0.7%
Q1 25
0.6%
Q4 24
0.6%
Q3 24
0.0%
0.4%
Q2 24
0.4%
Q1 24
0.6%
Cash Conversion
ACAD
ACAD
RVLV
RVLV
Q4 25
-0.18×
-0.55×
Q3 25
1.03×
0.56×
Q2 25
2.40×
1.24×
Q1 25
1.07×
3.82×
Q4 24
0.28×
0.32×
Q3 24
1.93×
0.83×
Q2 24
0.75×
-1.60×
Q1 24
1.76×
3.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

RVLV
RVLV

Fashion Apparel$155.1M48%
Dresses$76.4M24%
Handbags Shoes And Accessories$67.6M21%
Beauty$20.3M6%
Manufactured Product Other$5.0M2%
Breakage On Store Credit And Gift Cards$900.0K0%

Related Comparisons